Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 3,300 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
Journal of Inflammation Research, 2025Using Olink Proteomics to Identify Inflammatory Biomarkers in the Cerebrospinal Fluid in Guillain-Barré Syndrome
Sun S., Li M., Song J. et al.
Olink Target 96
Molecular Oncology, 2025Systematic profiling of cancer‐fibroblast interactions reveals drug combinations in ovarian cancer
Gudoityte G., Sharma O., Leuenberger L. et al.
International Journal of Cardiology Cardiovascular Risk and Prevention, 2025Circulating protein biomarkers and their association with vulnerable plaque characteristics – a PROSPECT II substudy
Sharma T., Maehara A., Maeng M. et al.
Journal of Cardiac Failure, 2025The Association between Serially Measured Circulating Biomarker Patterns and Pulmonary Artery Pressures measured by Invasive Hemodynamic Monitoring
de Jong M., Allach Y., Kamar S. et al.
Med, 2025Pre-treatment untargeted cerebrospinal fluid metabolomic profiling in tuberculous meningitis uncovers pathways associated with mortality
Le T., van Abeelen K., Ardiansyah E. et al.
Nature Communications, 2025The health impacts and genetic architecture of food liking in cardio-metabolic diseases
Jiang W., Wang H., Geng Y. et al.
Olink Explore 3072/384
Signal Transduction and Targeted Therapy, 2025Harnessing local and system immune profiling delineating differential responders to first-line sintilimab (anti-PD-1 antibody) combined with chemotherapy in extensive-stage small cell lung cancer: an exploratory biomarker analysis of a phase II study
Xie M., Bao M., Dong X. et al.
European Neuropsychopharmacology, 2025Predicted plasma proteomics from genetic scores and treatment outcomes in major depression: a meta-analysis
Oliva V., Possidente C., Fanelli G. et al.
Nature Communications, 2025FcRn-silencing of IL-12Fc prevents toxicity of local IL-12 therapy and prolongs survival in experimental glioblastoma
Beffinger M., Schellhammer L., Taskoparan B. et al.
Circulation, 2025Proteomic Signatures for Risk Prediction of Atrial Fibrillation
Park H., Norby F., Kim D. et al.
The American Journal of Clinical Nutrition, 2025Relationship of healthy lifestyle with healthy aging and the mediation by plasma proteins: a prospective cohort study
Fang F., Liu Z., Lyu J. et al.
Medicine, 2025Roles of plasma proteins in mediating the causal effect of the lipid species on gastric cancer: Insights from proteomic and two-step Mendelian randomization
Dong Z., Chen Z., Yu K. et al.
Journal of Interferon & Cytokine Research, 2025Significant Associations Between Blood Cell Counts and a Large Number of Salivary Cytokines, Chemokines, and Growth Factors
Eriksson L., Eriksson M., Gordh T. et al.
Nature Communications, 2025In depth transcriptomic profiling defines a landscape of dysfunctional immune responses in patients with VEXAS syndrome
Mizumaki H., Gao S., Wu Z. et al.
Blood Journal, 2025Ruxolitinib Targets JAK-STAT Signaling to Modulate Neutrophil Activation in Refractory Macrophage Activation Syndrome
Ma Y., Chen X., Wang M. et al.
Allergy, 2025Deciphering the Connection Between Atopic Dermatitis and Cardiovascular Diseases: Analysis of Clinical Associations and Cardiometabolic Proteins
Fehr D., Huynh‐Tran V., Maintz L. et al.
Brain and Behavior, 2025Causal Relationships Between the Gut Microbiota, Inflammatory Cytokines, and Amyotrophic Lateral Sclerosis: A Mendelian Randomization Analysis
Changqing L., Leying Y., Caiyun M. et al.
Discover Oncology, 2025Exploring the causal relationship between immune factors and chondrosarcoma: a Mendelian randomization study
Xu T., Xiao W., Li W. et al.
European Journal of Endocrinology, 2025Proteomic variation underlies the heterogeneous risk of metabolic dysfunction-associated steatotic liver disease for subsequent chronic diseases
Wu J., Wu G., Li J. et al.
Nature Communications, 2025SARS-CoV-2 induced immune perturbations in infants vary with disease severity and differ from adults’ responses
Nehar-Belaid D., Mejías A., Xu Z. et al.
3415 publications
Items per page
641-660 of 3415 publications